Nutrition Support for Head and Neck Squamous Cell Carcinoma Patients Treated with Chemoradiotherapy : How Often and How Long?

Abstract EN

Background.

Oral intake of many patients with locally advanced head and neck cancer (LAHNC) decrease during chemoradiotherapy (CRT).

Although prophylactic percutaneous endoscopic gastrostomy (PEG) is recommended, not a few patients complete CRT without using PEG tube.

Patients and Methods.

The subjects were patients with LAHNC who received CRT.

We retrospectively investigated the incidence and duration of nutritional support during and after CRT, and predicting factors of nutritional support.

For patients who required nutritional support, we also checked the day of initiation and the duration of nutritional support.

Results.

Of 53 patients, 29 patients (55%) required nutritional support during and/or after CRT.

While no clear relation between requirement of nutritional support and variables including age, T stage, N stage, clinical stage and chemotherapy regimen, there could be some relationships between tumor primary sites and the requirement and duration of nutritional support.

17 (77%) of 22 patients with oropharynx cancer(OP) required nutritional support and prolonged for 4.4 months, and 11 (46%) of 24 patients with hypopharynx cancer(HP) required nutritional support and prolonged for 21.9 months.

Conclusion.

Nutritional support is indicated many HNC patients treated with CRT and primary sites may have some relation to its indication and duration.